Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with ...
Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 grant ...
Hobbits of Flores evolved to be small by slowing down growth during childhood, new research on teeth and brain size suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback